Clinical Trials on Congenital Cystic Kidney Disease in Belgium

Total 726 results

Sanofi

Terminated

Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat (STAGED-PKD-EXT)

Congenital Cystic Kidney Disease

Germany, Spain, United States, Australia, Belgium, Japan, Korea, Republic of, Netherlands
Radboud University Medical Center
Ipsen

Unknown

Open-Label Extension of LOCKCYST Trial (LOCKCYST-ext)

Liver Diseases | Hepatomegaly | Polycystic Liver Disease | Polycystic Kidney | Autosomal Dominant

Netherlands, Belgium
Radboud University Medical Center
Ipsen

Completed

Lanreotide as Treatment of Polycystic Livers (LOCKCYST)

Liver Diseases | Polycystic Kidney, Autosomal Dominant | Hepatomegaly | Polycystic Liver Disease

Netherlands, Belgium
Andreas L. Serra

Unknown

The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe

Autosomal Dominant Polycystic Kidney Disease

France, Switzerland, Germany, Netherlands, Belgium, Czech Republic, Italy, Spain, Turkey, United Kingdom
Otsuka Pharmaceutical Europe Ltd

Unknown

A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe (ACQUIRE)

Autosomal Dominant Polycystic Kidney Disease

Spain, United Kingdom, Germany, France, Belgium, Switzerland, Austria
Galapagos NV

Terminated

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease

Belgium, Netherlands, Italy, Spain, Czechia, Germany, Poland
University Medical Center Groningen

Not yet recruiting

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life (HYDRO-PROTECT)

ADPKD

Netherlands, United Kingdom, Belgium, Germany, France, Spain
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Germany, Italy, Belgium, United Kingdom
Genzyme, a Sanofi Company

Terminated

A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients (STAGED-PKD)

Polycystic Kidney, Autosomal Dominant

Belgium, Germany, Czechia, United States, Italy, Poland, Argentina, Australia, Austria, Canada, China, Denmark, France, Israel, Japan, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Taiwan, Turkey, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Autosomal Recessive Polycystic Kidney Disease (ARPKD)

United States, Belgium, Spain, Germany, United Kingdom, Poland
Universitaire Ziekenhuizen KU Leuven

Recruiting

Endodontic Microsurgery With the Use of L-PRF Block

Apical Periodontitis | Apical Periodontal Cyst

Belgium
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Autosomal Recessive Polycystic Kidney (ARPKD)

United States, United Kingdom, Belgium, Poland, France, Germany, Italy
Universitaire Ziekenhuizen KU Leuven
University College, London; Wellcome Trust

Unknown

Fetal Surgery Interview Study: Parental Perceptions of Fetal Surgery

Congenital Diaphragmatic Hernia | Myelomeningocele | Fetal Surgery

Belgium, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Completed

Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney, Autosomal Dominant

Belgium, Germany, Italy, Spain, Sweden, United States, Canada, Australia, Netherlands, Czechia, Poland, Denmark, Israel, Hungary, Russian Federation, South Africa, United Kingdom, Romania, Argentina, Norway
University Hospital, Ghent

Completed

Aortic Valve Dynamics During Exercise After Valve Sparing Root Replacement Surgery

Aneurysm Aortic Root | Aortic Valve, Bicuspid

Belgium
Otsuka Pharmaceutical Development & Commercialization...

Completed

Tolvaptan Extension Study in Participants With ADPKD (TEMPO 4/4)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States, Australia, Belgium, Germany, Italy, Poland, Romania, United Kingdom, Argentina, Canada, France, Netherlands, Russian Federation
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (TEMPO3:4)

Polycystic Kidney Disease, Autosomal Dominant

United States, Belgium, United Kingdom, Russian Federation, France, Australia, Netherlands, Italy, Japan, Denmark, Romania, Poland, Canada, Argentina, Germany
C. R. Bard

Terminated

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation (WAVE-Global)

Chronic Kidney Diseases | End Stage Kidney Disease | Kidney Disease, Chronic | Kidney Failure | AV Fistula | Kidney Insufficiency | Fistulas Arteriovenous

Switzerland, Belgium, Greece
Brugmann University Hospital

Recruiting

Arteriovenous Fistula Maturation in Hemodialysis Patients With or Without Positive Antiphospholipid Antibodies

Chronic Kidney Diseases

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Vaccination Coverage and Level of Protection in Patients at Risk

Diabetes | Allergy | Chronic Kidney Disease | Cystic Fibrosis | Heart Disease

Belgium
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease (OVERTURE)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Italy, Japan, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
Universitaire Ziekenhuizen KU Leuven

Completed

An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience

Spinal Dysraphism | Chiari Malformation Type 2 | Fetal Anomaly

Belgium
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

Chronic Kidney Disease | Autosomal Dominant Polycystic Kidney Disease

Australia, Belgium, Italy, Spain, Sweden, United States, Canada, Netherlands, Czechia, Poland, Germany, Russian Federation, Hungary, Israel, Puerto Rico, Argentina, Denmark, South Africa, United Kingdom, Norway, France, Romania
KU Leuven

Completed

Start-to-Sport - Home-based Exercise for Adolescents and Adults With Congenital Heart Disease (S2S-ACHD)

Congenital Heart Defect

Belgium
Pierre Wauthy

Completed

Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.

Congenital Heart Defect

Belgium
Queen Fabiola Children's University Hospital

Terminated

Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants. (DIETCHIRCARD)

Congenital Heart Disease in Children

Belgium
European Society of Intensive Care Medicine

Completed

PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy (PEACE)

Acute Kidney Injury | Renal Replacement Therapy | Chronic End Stage Kidney Disease

Belgium
University Hospital, Ghent
Universiteit Antwerpen

Completed

Evaluation of Transition With a Heart, a Transition Program for Adolescents With Congenital Heart Disease and Parents

Transitional Care | Congenital Heart Disease in Adolescence

Belgium
Brugmann University Hospital

Completed

Influence of Intraoperative Fluid Balance on the Incidence of Adverse Events in Pediatric Cardiac Surgery

Surgery | Fluid Overload | Congenital Heart Disease in Children

Belgium
Reata, a wholly owned subsidiary of Biogen

Terminated

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (FALCON)

Autosomal Dominant Polycystic Kidney | ADPKD

United States, Spain, United Kingdom, Australia, France, Japan, Germany, Belgium, Czechia, Italy
Universitaire Ziekenhuizen KU Leuven

Completed

Multidisciplinary Care for Patients With Chronic Kidney Disease to Increase Their Self-management.

Chronic Kidney Diseases

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Outcome of Patients With Congenital Heart Disease (OUTCARDIOP)

Congenital Heart Disease

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Postoperative Troponin in Children With Congenital Heart Disease

Congenital Heart Disease

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

The Value of Three Dimensional Echocardiography in Congenital Cardiac Surgery

Congenital Heart Disease

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Fresh Frozen Plasma and Plasmalyte ® for Priming Cardiopulmonary Bypass in Infants and Children

Congenital Heart Disease

Belgium
Universiteit Antwerpen

Unknown

Prenatal Screening for Congenital Heart Diseases in the Antwerp Region (SEC)

Congenital Heart Disease in Pregnancy

Belgium
Brugmann University Hospital

Completed

Predictive Pre and Peroperative Factors for MODS-2 in Pediatric Cardiac Surgery (FPMODS2)

Congenital Heart Disease in Children | Cardiac Surgical Procedures | Outcome Assessment | Organ Dysfunction Scores

Belgium
Pierre Wauthy

Completed

Morbimortality of Contegra Duct Replacements Versus Homografts in Pulmonary Position

Congenital Heart Disease

Belgium
Queen Fabiola Children's University Hospital

Unknown

Long Term Results in Hypoplastic Aortic Arch Repair in Neonates Using a Glutaraldehyde Treated Autologous Pericardial Patch (Aortoplasty)

Congenital Hypoplasia of Aortic Arch

Belgium
Cliniques universitaires Saint-Luc- Université...
Fonds National de la Recherche Scientifique

Unknown

The Prognostic Role of the Right Ventricle in Patients With Heart Failure or Congenital Heart Disease (RV-STRAIN)

Heart Failure

Belgium
Queen Fabiola Children's University Hospital

Completed

Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns

Congenital Heart Defect | Right Ventricular Outflow Tract Reconstruction

Belgium
Universitaire Ziekenhuizen KU Leuven
General Hospital Groeninge

Completed

Nephrocare mHealth Project: Telemonitoring of Blood Pressure (Nephrocare)

Chronic Kidney Diseases | Blood Pressure

Belgium
KU Leuven
Hasselt University; University Hospital, Ghent

Recruiting

Accelerated Aging in Newborns and Adults With Congenital Heart Disease (AccelerAGE)

Heart Defects, Congenital

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis (UToPaed_2)

Chronic Kidney Disease

Belgium
University of Liege

Completed

Impact of Virtual Reality Hypno-sedation on Functional Recovery and Anxiety in Foot Surgery With Regional Anesthesia

Analgesia | Foot Deformities | Regional Anesthesia Morbidity | Valgus; Hallux

Belgium
Brugmann University Hospital

Not yet recruiting

Perioperative Transfusion Strategies in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery

Cardiac Surgery | Congenital Heart Disease | Blood Transfusion | Morbidity, Multiple

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants. (NIVNAVA)

Surgery | Heart Defects, Congenital

Belgium
Pierre Wauthy

Completed

Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.

Congenital Heart Disease

Belgium
University Hospital, Ghent

Completed

Uremic Toxins of Patients With Acute Kidney Failure

Kidney Failure, Acute

Belgium
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects (CHF6333 FIH)

Cystic Fibrosis | Non-Cystic Fibrosis Bronchiectasis

Belgium

Clinical Trials on Congenital Cystic Kidney Disease in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations